Atherothrombosis as a systemic disease

Cerebrovascular Diseases

Volumn 13, Issue SUPPL. 1, 2002, Pages 1-6

  Drouet, Ludovic ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Atherosclerosis; Atherothrombosis; Platelets; Stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ARTERY DIAMETER; ARTERY OCCLUSION; ARTERY THROMBOSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONFERENCE PAPER; CORONARY BLOOD VESSEL; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; MICROEMBOLISM; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; Q WAVE; SMOOTH MUSCLE FIBER; SYSTEMIC DISEASE; THROMBOCYTE RICH PLASMA; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS;

EID: 0036151594     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047782     Document Type: Conference Paper

References (29)

1. Unifying concept of arterial vascular disease
2. Atherothrombosis: The role of platelets
3. Collaborative overview of randomised trials of anti-platelet therapy - I: Prevention of death, myocardial infarction and stroke by prolonged anti-platelet therapy in various categories of patients
4. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Lewis A. Conner Memorial Lecture
5. Molecular basis of the acute coronary syndromes
6. Cardiology in the 21st century
7. C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes
8. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
9. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
10. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction
11. Stability and instability: Two faces of coronary atherosclerosis: The Paul Dudley White Lecture 1995
12. Compensatory enlargement of human atherosclerotic coronary arteries
13. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture
14. Recognition of the importance of embolization in atherosclerotic vascular disease
15. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis
16. Compensatory arterial enlargement is a common pathobiologic response in early atherosclerosis
17. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis
18. Three-dimensional analysis of human carotid atherosclerotic ulcer associated with recent thrombotic occlusion
19. Plaque ulceration and lumen thrombosis are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis
20. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro
21. Relationship of arterial geometry and arterial narrowing and histologic markers for plaque vulnerability: The remodelling index
22. Relation of plaque lipid composition and morphology to the stability of human aortic plaques
23. Acute limb ischemia
24. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
25. Atherothrombotic events often indicate disseminated atherosclerosis: Data from CAPRIE
26. Distribution of symptomatic atherothrombosis and influence of atherosclerotic disease burden on risk of secondary ischaemic events: Results from CAPRIE
27. The epidemiology of peripheral arterial disease: Importance of identifying the population at risk
28. The risk of vascular ischaemic events in patients with various clinical manifestations of atherothrombosis: Data from CAPRIE
29. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology